Ultrasound-guided closure of the femoral artery during venoarterial decannulation using a large-bore closure device.


Journal

Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society
ISSN: 1799-7267
Titre abrégé: Scand J Surg
Pays: England
ID NLM: 101144297

Informations de publication

Date de publication:
Dec 2023
Historique:
medline: 1 12 2023
pubmed: 10 7 2023
entrez: 10 7 2023
Statut: ppublish

Résumé

Peripheral femoro-femoral venoarterial extracorporeal membrane oxygenation (VA-ECMO) is viable for fast hemodynamic assistance during cardiogenic shock. Ultrasound-guided closure with a large-bore device (MANTA This retrospective study included patients weaning from percutaneously inserted femoro-femoral VA-ECMO at the Helsinki University Hospital, Finland in 2012-2020. The primary endpoints were access-site complications, a composite of hematomas/seromas/surgical site infections (SSIs), and the safety endpoint of vascular complications (VCs). A total of 100 consecutive percutaneously implanted and weaned VA-ECMO patients were stratified into two groups by decannulation strategy: percutaneous ultrasound-guided MANTA device ( Percutaneous ultrasound-guided MANTA closure of the femoral artery after VA-ECMO decannulation was associated with high technical success rate and low incidence of VCs. Compared to surgical closure, access-site complications were significantly less frequent, along with access-site complications necessitating interventions.

Sections du résumé

BACKGROUND UNASSIGNED
Peripheral femoro-femoral venoarterial extracorporeal membrane oxygenation (VA-ECMO) is viable for fast hemodynamic assistance during cardiogenic shock. Ultrasound-guided closure with a large-bore device (MANTA
METHODS UNASSIGNED
This retrospective study included patients weaning from percutaneously inserted femoro-femoral VA-ECMO at the Helsinki University Hospital, Finland in 2012-2020. The primary endpoints were access-site complications, a composite of hematomas/seromas/surgical site infections (SSIs), and the safety endpoint of vascular complications (VCs).
RESULTS UNASSIGNED
A total of 100 consecutive percutaneously implanted and weaned VA-ECMO patients were stratified into two groups by decannulation strategy: percutaneous ultrasound-guided MANTA device (
CONCLUSIONS UNASSIGNED
Percutaneous ultrasound-guided MANTA closure of the femoral artery after VA-ECMO decannulation was associated with high technical success rate and low incidence of VCs. Compared to surgical closure, access-site complications were significantly less frequent, along with access-site complications necessitating interventions.

Identifiants

pubmed: 37427753
doi: 10.1177/14574969231181232
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

256-264

Déclaration de conflit d'intérêts

Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Auteurs

Tasnia Rahman (T)

Heart and Lung CenterUniversity of Helsinki and Helsinki University Hospital, Haartmaninkatu 4, Helsinki 00290, Finland.

Johanna Herajärvi (J)

Heart and Lung Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Research Unit of Surgery, Anesthesia and Critical Care, University of Oulu, Oulu, Finland.

Henri Ahonen (H)

Heart and Lung Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Mikko Jormalainen (M)

Heart and Lung Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Simo Syrjälä (S)

Heart and Lung Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Tommi Järvinen (T)

Heart and Lung Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Tatu Juvonen (T)

Heart and Lung Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Research Unit of Surgery, Anesthesia and Critical Care, University of Oulu, Oulu, Finland.

Sebastian Dahlbacka (S)

Heart and Lung Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH